UTHR United Therapeutics Corporation

$474.72

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/21/2025

About United Therapeutics Corporation

United Therapeutics Corporation, a biotechnology company, is dedicated to the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company is headquartered in Silver Spring, Maryland.

Website: https://www.unither.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1082554
Address
1040 SPRING ST, SILVER SPRING, MD, US
Valuation
Market Cap
$12.79B
P/E Ratio
11.56
PEG Ratio
1.44
Price to Book
1.98
Performance
EPS
$24.63
Dividend Yield
—
Profit Margin
41.50%
ROE
19.20%
Technicals
50D MA
$320.06
200D MA
$345.84
52W High
$417.81
52W Low
$233.28
Fundamentals
Shares Outstanding
45M
Target Price
$394.93
Beta
0.63

UTHR EPS Estimates vs Actual

● Estimated
● Actual

UTHR News & Sentiment

Nov 21, 2025 • Zacks Commentary BULLISH
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Nov 20, 2025 • Zacks Commentary BULLISH
Here's Why United Therapeutics ( UTHR ) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Nov 19, 2025 • Benzinga SOMEWHAT-BULLISH
Here's How Much $100 Invested In United Therapeutics 15 Years Ago Would Be Worth Today - United Therapeutics ( NASDAQ:UTHR )
United Therapeutics ( NASDAQ:UTHR ) has outperformed the market over the past 15 years by 2.35% on an annualized basis producing an average annual return of 14.5%. Currently, United Therapeutics has a market capitalization of $20.42 billion.
Nov 19, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Merck Stock Rise as New PAH Drug Winrevair Meets Goal in Another Study
MRK's Winrevair hits its phase II goal in patients with CpcPH tied to HFpEF, setting up phase III plans and a potential path to broader use. Stock up.
Nov 12, 2025 • Zacks Commentary BULLISH
Why United Therapeutics ( UTHR ) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Nov 12, 2025 • Zacks Commentary BULLISH
Is First Trust Growth Strength ETF ( FTGS ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Sentiment Snapshot

Average Sentiment Score:

0.281
50 articles with scored sentiment

Overall Sentiment:

Bullish

UTHR Reported Earnings

Jul 30, 2025
Jun 30, 2025 (Pre market)
-0.94 Surprise
  • Reported EPS: $6.41
  • Estimate: $7.35
  • Whisper: —
  • Surprise %: -12.8%
Apr 30, 2025
Mar 31, 2025 (Pre market)
-0.03 Surprise
  • Reported EPS: $6.63
  • Estimate: $6.66
  • Whisper: —
  • Surprise %: -0.5%
Feb 26, 2025
Dec 31, 2024 (Pre market)
-0.08 Surprise
  • Reported EPS: $6.19
  • Estimate: $6.27
  • Whisper: —
  • Surprise %: -1.2%
Oct 30, 2024
Sep 30, 2024 (Pre market)
-0.04 Surprise
  • Reported EPS: $6.39
  • Estimate: $6.43
  • Whisper: —
  • Surprise %: -0.6%
Jul 31, 2024
Jun 30, 2024 (Pre market)
-0.55 Surprise
  • Reported EPS: $5.85
  • Estimate: $6.40
  • Whisper: —
  • Surprise %: -8.6%
May 01, 2024
Mar 31, 2024 (Pre market)
0.52 Surprise
  • Reported EPS: $6.17
  • Estimate: $5.65
  • Whisper: —
  • Surprise %: 9.2%
Feb 21, 2024
Dec 31, 2023 (Pre market)
0.17 Surprise
  • Reported EPS: $4.36
  • Estimate: $4.19
  • Whisper: —
  • Surprise %: 4.1%
Nov 01, 2023
Sep 30, 2023 (Pre market)
0.34 Surprise
  • Reported EPS: $5.38
  • Estimate: $5.04
  • Whisper: —
  • Surprise %: 6.8%
Aug 02, 2023
Jun 30, 2023 (Pre market)
0.73 Surprise
  • Reported EPS: $5.24
  • Estimate: $4.51
  • Whisper: —
  • Surprise %: 16.2%

Financials